Navigation Links
Verenium Announces First Commercial Cellulosic Ethanol Project

- Large-scale cellulosic ethanol facility in Florida to serve as model for future plants -

- "Farm to Fuel" grant provides State support to project -

CAMBRIDGE, Mass., Jan. 15 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced plans to build its first commercial-scale cellulosic ethanol facility in Highlands County, Florida. The Company has entered into long-term agreements with Lykes Bros. Inc., a multi-generation Florida agri-business to provide the agricultural biomass for conversion to fuel. Verenium also announced that the Highlands Ethanol project has been awarded a $7 million grant as part of Florida's "Farm to Fuel" initiative. These announcements will be discussed today at a press briefing at the Florida Department of Agriculture and Consumer Services in Tallahassee, Florida.

Verenium's planned commercial facility will be the first in the State of Florida to use next-generation cellulosic ethanol technology to convert renewable grasses to fuel, rather than processing food crops. The plant will be constructed on fallow land, and is expected to produce up to 36 million gallons of cellulosic ethanol per year and provide the region with about 140 full-time jobs, once commercial operations begin. Verenium anticipates breaking ground on this facility in the second half of this year, and expects to start producing fuel in 2011. Additional jobs will be created during the 18-to-24 months of construction on the plant, which is estimated to cost between $250 and $300 million to build. Verenium recently received a special use permit from Highlands County for this facility, located in South Central Florida, and is in the process of finalizing other necessary permit applications.

"This plant, the first of many we anticipate building in the years ahead, will help fulfill the U.S. government's mandate for advanced, sustainable biofuels to meet America's energy needs," said Carlos A. Riva, Verenium's President and Chief Executive Officer. "The facility will serve as a blueprint for how we develop future projects. This milestone is just the beginning."

Riva said the strategic partnership with Lykes Bros. provides the basis for a long-term supply of agricultural feedstock, essential to ensuring next-generation biofuels are cost-efficient. The Florida project is the first of several the Company has under development.

The Highlands Ethanol Project

The agreements between Verenium and Lykes Bros. include a facility site option and a long-term farm lease. Under these agreements, Lykes will provide the necessary feedstock from approximately 20,000 farmable acres adjacent to the site.

The project has been awarded a $7 million grant under Florida Agriculture and Consumer Services Commissioner Charles H. Bronson's "Farm to Fuel" initiative, designed to stimulate the development of a renewable energy industry in Florida. This $25 million program provides matching grants to bio-energy firms for demonstration, commercialization and research and development projects utilizing Florida-grown biomass or crops. Verenium was also awarded an additional incentive package from the State of Florida.

"The message today is that Florida's agricultural industry can produce fuel crops on a major commercial scale without sacrificing food crops," Bronson said. "This is a major step forward for our 'Farm to Fuel' program and hopefully will serve as a catalyst for additional investment by companies interested in producing renewable energy in Florida."

Howell Ferguson, CEO and Chairman of the Board of Lykes Bros. commented, "We foresee great potential for fuel production from biomass, and we believe that it will offer significant benefits for the U.S. and for agriculture throughout Florida. It is exciting to join in a project using cellulosic ethanol technology pioneered at the University of Florida Institute of Food and Agricultural Science, and we are very pleased to work with Verenium on this project."

Verenium's conversion process originated from the landmark technology developed by a team led by Dr. Lonnie Ingram at the University of Florida.

The grant agreement, which Verenium and Florida Commissioner of Agriculture and Consumer Services Charles Bronson will discuss at a press briefing at the Florida State Capitol in Tallahassee today, follows Verenium's success at its pilot- and demonstration-scale plants in Jennings, La., where the Company has been developing and testing processes to optimize production and lower the cost of making cellulosic ethanol.

Separately, in August Verenium announced a strategic partnership with BP, an international energy company and leader in alternative energy, to speed the development of its cellulosic ethanol technology. Verenium and BP are currently focusing on a second phase of collaboration surrounding the development and deployment of commercial-scale cellulosic ethanol production facilities.

Cellulosic Ethanol

Cellulosic ethanol is a renewable fuel source produced from natural, plant waste products and dedicated energy feedstocks such as sugarcane waste (bagasse), switchgrass, sorghum, rice straw and wood chips. Cellulose, a long-chain polysaccharide found in nearly all plant life, is the most abundant organic polymer on earth. The Environmental Protection Agency says cellulosic ethanol's high-oxygen content reduces carbon monoxide better than other oxygenates.

Next-generation cellulosic ethanol uses advanced enzyme science to reduce the cost of ethanol production and enable access to a wide variety of biomass. Unlike traditional ethanol manufactured from corn or sugar, cellulosic ethanol production utilizes non-food, plant biomass as its feedstock source. The biomass is first broken down into fermentable sugars using acid or enzymatic hydrolysis and industrial enzymes, after which the sugars are fermented into ethanol using various fermentation organisms. Ethanol produced from cellulosic biomass is believed to have many benefits over first-generation ethanol including, the use of non-food feedstock, substantially greater yield of ethanol per acre of feedstock, minimal exposure to volatile commodity price risks, and a more favorable environmental impact.

About Verenium

Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and health and nutrition markets. The Company possesses integrated, end-to-end capabilities in pre-treatment, novel enzyme development, fermentation, engineering, and project development and is moving rapidly to commercialize its proprietary technology for the production of ethanol from a wide array of feedstocks, including sugarcane bagasse, dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities exist for the Company for products derived from the production of low-cost, biomass-derived sugars.

Verenium's Specialty Enzyme business harnesses the power of enzymes to create a broad range of specialty products to meet high-value commercial needs. Verenium's world class R&D organization is renowned for its capabilities in the rapid screening, identification, and expression of enzymes-proteins that act as the catalysts of biochemical reactions. For more information on Verenium, visit

Forward Looking Statements

Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty. These include statements related to the Company's operations, capabilities, commercialization activities, target markets and cellulosic ethanol facilities, all of which are prospective. Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's new and uncertain technologies, risks associated with the costs, labor requirements and labor availability associated with Verenium's demonstration plant, risks associated with Verenium's ability to obtain additional capital to support its planned operations, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, technological, regulatory, competitive and other risks related to development, production, and commercialization of cellulosic ethanol and other biofuels and the commercial prospects of those industries, Verenium's dependence on existing collaboration, manufacturing, and/or license agreements, and its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize products (including by obtaining any required regulatory approvals) using Verenium's technologies and timing for launching any commercialized products, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture agreements and licenses, changes in the U.S. or global energy markets and laws and regulations applicable to them, and risks and other uncertainties more fully described in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's quarterly report on Form 10-Q for the three months ended September 30, 2008. These forward-looking statements speak only as of the date hereof. The Company expressly disclaims any intent or obligation to update these forward-looking statements.

    Kelly Lindenboom
    Vice President, Corporate Communications

    Sarah Carmody
    Sr. Corporate Communications Associate

SOURCE Verenium Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
2. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
3. Verenium Corporation to Announce Third Quarter 2008 Financial Results
4. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
5. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
6. Verenium Appoints John F. Dee to Board of Directors
7. Verenium Reports Financial Results for the First Quarter 2008
8. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
9. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
10. Verenium Corporation to Present at the Pacific Growth Equities 2007 Clean Technology & Industrial Growth Conference
11. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Capricor Therapeutics, Inc. ... the discovery, development and commercialization of first-in-class therapeutics, today ... Officer, is scheduled to present at the 2015 Piper ... a.m. EST, at The Lotte New York Palace Hotel ... . --> . ...
(Date:11/24/2015)... VILLAGE, Nev. , Nov. 24, 2015  PDL BioPharma, ... John P. McLaughlin , the company,s president and chief executive ... Jaffray Healthcare Conference next week in New York ... will occur on Tuesday, December 1, 2015 at 9:30 a.m. ... Presentations." Please connect to the website at least 15 minutes ...
(Date:11/24/2015)... ... November 24, 2015 , ... Whitehouse Laboratories is pleased to announce that ... facility will be strictly dedicated to basic USP 61, USP 62 and USP 51 ... to have complete chemistry and micro testing performed by one supplier. Management ...
(Date:11/23/2015)... Women with a certain type of lung nodule ... risk of lung cancer than men with similar nodules, according ... annual meeting of the Radiological Society of North ... --> Lung nodules are small masses of tissue ... based on their appearance on CT. Solid nodules are dense, ...
Breaking Biology Technology:
(Date:10/29/2015)... YORK , Oct. 29, 2015 ... technology, announced a partnership with 2XU, a global ... to deliver a smart hat with advanced bio-sensing ... and other athletes to monitor key biometrics to ... the strategic partnership, the two companies will bring together ...
(Date:10/27/2015)... BERLIN, Germany , October 27, 2015 ... 2015. SMI,s Automated Semantic Gaze Mapping technology (ASGM) automatically ... SMI,s Eye Tracking Glasses , so that ... Suite BeGaze. --> Munich, Germany ... technology (ASGM) automatically maps data from mobile eye tracking ...
(Date:10/26/2015)... India , October 26, 2015 ... --> adds ... 2015 to 2021 as well as ... 2015-2019 research reports to its collection ... . --> ...
Breaking Biology News(10 mins):